Metraipolis › archive › dc_4c70e77fbc80

Is radioiodine necessary for patients with low-risk differentiated thyroid cancer after thyroidectomy: a pooled analysis of ESTIMABL2 and IoN trials — Europe PMC PMID:41229489

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41229489
DOI
10.3389/fonc.2025.1670978
License (as archived)
solo-consultazione
Archived
2026-11-08T23:50:27.217Z
SHA-256 of the archived text
51fcf0cf9e92bb9d82c7cc407143fe18dd6f622c864f5f04c6550cbe1637c150
Stable URL of this page
https://metraipolis.com/documento/dc_4c70e77fbc80

How to cite

Is radioiodine necessary for patients with low-risk differentiated thyroid cancer after thyroidectomy: a pooled analysis of ESTIMABL2 and IoN trials — Europe PMC PMID:41229489 — Europe PMC (en), https://europepmc.org/article/MED/41229489 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4c70e77fbc80 (Metraipolis archive dc_4c70e77fbc80, sha256 51fcf0cf9e92bb9d82c7cc407143fe18dd6f622c864f5f04c6550cbe1637c150)
BibTeX
@misc{dc4c70e77fbc80,
  title = {Is radioiodine necessary for patients with low-risk differentiated thyroid cancer after thyroidectomy: a pooled analysis of ESTIMABL2 and IoN trials — Europe PMC PMID:41229489},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41229489},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4c70e77fbc80; sha256 51fcf0cf9e92bb9d82c7cc407143fe18dd6f622c864f5f04c6550cbe1637c150},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41229489. Agents can read the archived copy with the MCP tool read_document.